Artificial intelligence–coupled plasmonic infrared sensor for detection of structural protein biomarkers in neurodegenerative diseases
Science Advances,
Journal Year:
2023,
Volume and Issue:
9(28)
Published: July 12, 2023
Diagnosis
of
neurodegenerative
disorders
(NDDs)
including
Parkinson's
disease
and
Alzheimer's
is
challenging
owing
to
the
lack
tools
detect
preclinical
biomarkers.
The
misfolding
proteins
into
oligomeric
fibrillar
aggregates
plays
an
important
role
in
development
progression
NDDs,
thus
underscoring
need
for
structural
biomarker-based
diagnostics.
We
developed
immunoassay-coupled
nanoplasmonic
infrared
metasurface
sensor
that
detects
linked
such
as
alpha-synuclein,
with
specificity
differentiates
distinct
species
using
their
unique
absorption
signatures.
augmented
artificial
neural
network
enabling
unprecedented
quantitative
prediction
protein
mixture.
microfluidic
integrated
can
retrieve
time-resolved
absorbance
fingerprints
presence
a
complex
biomatrix
capable
multiplexing
simultaneous
monitoring
multiple
pathology-associated
Thus,
our
promising
candidate
clinical
diagnosis
monitoring,
evaluation
novel
therapies.
Language: Английский
Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders
Acta Neuropathologica Communications,
Journal Year:
2022,
Volume and Issue:
10(1)
Published: Nov. 12, 2022
Abstract
Alpha-synuclein
(aSyn)
is
a
pre-synaptic
monomeric
protein
that
can
form
aggregates
in
neurons
Parkinson’s
disease
(PD),
with
dementia
(PDD)
and
Lewy
bodies
(DLB),
oligodendrocytes
multiple
system
atrophy
(MSA).
Although
aSyn
astrocytes
has
previously
been
described
PD,
PDD
DLB,
the
biochemical
properties
topographical
distribution
of
astrocytic
have
not
studied
detail.
Here,
we
present
systematic
investigation
pathology
using
an
expanded
antibody
toolset
covering
entire
sequence
key
post-translational
modifications
(PTMs)
body
disorders
(LBDs)
MSA.
Astrocytic
was
detected
limbic
cortical
regions
LBDs
but
were
absent
main
pathological
The
revealed
only
antibodies
against
mid
N-terminal
non-amyloid
component
(NAC)
residues
34–99.
astroglial
accumulations
negative
to
canonical
aggregation
markers,
including
p62,
ubiquitin
pS129,
positive
for
phosphorylated
nitrated
forms
at
Tyrosine
39
(Y39),
resistant
proteinase
K.
Our
findings
suggest
represent
major
part
possess
distinct
PTM
signature
characterized
by
both
N-
C-terminal
truncations
Y39.
This
first
description
are
made
solely
from
C-terminally
cleaved
species
report
demonstrating
mixture
Y39
species.
These
observations
underscore
importance
characterization
different
cell
types
capture
diversity
brain.
combined
further
studies
on
role
progression
pave
way
towards
identifying
novel
mechanisms
therapeutic
targets.
Language: Английский
Application of Nanobiosensor Engineering in the Diagnosis of Neurodegenerative Disorders
Results in Engineering,
Journal Year:
2024,
Volume and Issue:
24, P. 102790 - 102790
Published: Sept. 5, 2024
Language: Английский
A Versatile Method for Site-Specific Chemical Installation of Aromatic Posttranslational Modification Analogs into Proteins
Xiaoxi Lin,
No information about this author
Shaswati Mandal,
No information about this author
Raj V. Nithun
No information about this author
et al.
Published: June 17, 2024
Posttranslational
modifications
(PTMs)
of
proteins
play
central
roles
in
regulating
protein
structure,
interactome,
and
functions.
A
notable
modification
site
is
the
aromatic
side
chain
Tyr,
which
undergoes
modifications,
such
as
phosphorylation
nitration.
Despite
biological
physiological
importance
Tyr-PTMs,
our
current
understanding
mechanisms
by
these
contribute
to
human
health
disease
remains
incomplete.
This
knowledge
gap
arises
from
absence
natural
amino
acids
that
can
mimic
PTMs
lack
synthetic
tools
for
site-specific
introduction
into
proteins.
Herein,
we
describe
a
facile
method
chemical
installation
through
palladium-mediate
S-C(sp2)
bond
formation
under
ambient
conditions.
We
demonstrate
incorporation
novel
Tyr-nitration
analogs
recombinantly
expressed
Cys-containing
peptides
within
minutes
good
yield.
To
versatility
approach,
employed
it
prepare
10
site-specifically
modified
proteins,
including
nitrated
Myc
Max
Furthermore,
prepared
focused
library
phosphorylated
α-Syn
protein,
enabled
first
time
deciphering
role
competing
conformation
aggregation
vitro.
Our
strategy
offers
advantages
over
or
semi-synthetic
approaches,
enables
rapid
selective
transfer
rarely
explored
recombinant
thus
facilitating
generation
libraries
homogeneous
post-translationally
biomarkers
discovery,
mechanistic
studies,
drug
discovery.
Language: Английский
Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2022,
Volume and Issue:
unknown
Published: May 29, 2022
ABSTRACT
Alpha-synuclein
(aSyn)
is
a
pre-synaptic
monomeric
protein
that
can
form
aggregates
in
neurons
Parkinson’s
disease
(PD),
with
dementia
(PDD)
and
Lewy
bodies
(DLB),
oligodendrocytes
multiple
system
atrophy
(MSA).
Although
the
accumulation
of
aSyn
astrocytes
has
previously
been
described
PD,
PDD
DLB,
biochemical
properties
this
type
pathology
its
topographical
distribution
have
not
studied
detail.
Here,
we
present
systematic
investigation
astrocytic
pathology,
using
an
expanded
toolset
antibodies
covering
entire
sequence
known
post-translational
modifications
(PTMs)
body
(LB)
disorders,
including
sporadic
PDD,
familial
PD
SNCA
G51D
mutation
duplication,
MSA.
Astrocytic
was
mainly
detected
limbic
cortical
regions
LB
but
were
absent
key
pathological
These
accumulations
only
against
mid
N-terminal
non-amyloid
component
(NAC)
residues
34-99.
The
astroglial
negative
to
canonical
aggregation
markers,
p62,
ubiquitin
pS129,
positive
for
phosphorylated
nitrated
forms
at
Tyrosine
39
(Y39),
mostly
resistant
proteinase
K.
Our
findings
suggest
are
major
part
possess
distinct
PTM
signature
characterized
by
both
N-
C-terminal
truncations
Y39.
To
best
our
knowledge,
first
description
made
solely
from
C-terminally
cleaved
species
report
demonstrating
exists
as
mixture
Y39
species.
observations
underscore
critical
importance
characterization
different
cell
types
necessary
step
capturing
diversity
brain.
combined
further
studies
on
role
progression
disorders
pave
way
towards
identifying
novel
mechanisms
therapeutic
targets.
Language: Английский
Alpha-synuclein distribution and seeding activity in rectal biopsies in Parkinson’s disease
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: March 29, 2024
Abstract
Background
Parkinson’s
disease
(PD)
is
characterized
by
the
accumulation
of
alpha-synuclein
(aSyn)
pathology,
not
only
in
brain
but
also
gastrointestinal
(GI)
tract.
This
study
investigates
use
unique
aSyn
antibodies
and
an
seed
amplification
assay
(SAA)
for
detecting
pathological
rectal
biopsy
samples
from
PD
patients
healthy
individuals.
These
were
preserved
using
formalin-fixed
paraffin-embedded
(FFPE)
methods.
Materials
Methods
The
analyzed
seeding
capacity
FFPE
submucosal
biopsies
24
20
controls
aSyn-SAA.
distribution
was
examined
immunohistochemistry
with
targeting
specific
conformations
phosphorylated
forms
at
S129
Y39.
Results
Pathological
found
all
patients,
as
confirmed
SAA,
these
linked
to
severity
motor
symptoms
(MDS-UPDRS-III).
However,
immunoreactive
patterns
conformation-specific
or
did
show
notable
differences
between
subjects.
Conclusion
strains
are
detectable
high
accuracy
utility
immunohistochemical
detection
current
identifying
appears
limited.
findings
advocate
aSyn-SAA
a
diagnostic
tool
PD,
contributing
deeper
understanding
gut-brain
connection
disease.
Language: Английский
Dissecting the differential role of C-terminal truncations in the regulation of aSyn pathology formation and the biogenesis of Lewy bodies
Anne-Laure Mahul-Mellier,
No information about this author
Melek Firat Altay,
No information about this author
Niran Maharjan
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 30, 2024
Alpha-synuclein
(aSyn)
post-translational
modifications
(PTMs),
particularly
phosphorylation
at
serine
129
and
C-terminal
truncations,
are
highly
enriched
in
Lewy
bodies
(LBs),
neurites,
other
types
of
aSyn
pathological
aggregates
the
brain
patients
with
Parkinson's
disease
(PD)
synucleinopathies.
However,
our
knowledge
about
precise
role
PTMs
regulating
different
stages
pathology
formation,
neurodegeneration,
spreading
remains
incomplete.
In
this
work,
we
applied
a
systematic
approach
to
address
gap
an
emphasis
on
mapping
elucidating
post-fibrillization
truncations
uptake,
processing,
seeding
activity,
formation
LB-like
inclusions
maturations
well-established
neuronal
model
that
recapitulates
all
leading
LB
neurodegeneration.
Our
work
shows
cleavage
fibrils
multiple
sites
is
conserved
process
occurs
rapidly
after
during
intracellular
models.
Interestingly,
blocking
internalized
does
not
influence
their
whereas
inhibiting
enzymes
regulate
newly
formed
(e.g.,
calpains
1
2)
significantly
alters
inclusions.
We
also
show
combination
PTMs,
play
crucial
interactome
remodeling
fibrils,
including
shortening,
lateral
association,
packing
maturation.
Altogether,
results
demonstrate
have
differential
aggregation
formation.
These
insights,
combined
abundance
truncated
species
LBs,
significant
implications
understanding
diversity
developing
therapeutic
strategies
targeting
C-terminus
or
its
proteolytic
processing.
Language: Английский